The potential for clinical application of the LC-based single-substrate biosensor was demonstrated with an immunoassay for the cancer biomarker CA125, in which the LOD was determined as 10−5-g/mL CA125 at an anti-CA125 antibody concentration of 10−7 g/mL for the E7 film. This evidence concerns the gene MUC16 and cancer.